Early Access — free while we kick the tires
EdgarHawk

McLaughlin Shawn Patrick

Director

Director

Latest: Director buying · April 2026

11 filings analyzed · 1 company · Latest 2026-04-29

Companies

Company Buys Sells Direction
Burke & Herbert Financial Services Corp. BHRB 12 0 Net buying

Activity

April 2026
Buy
1,000 shares
$63,548
Significance 6/10

Director Shawn Patrick McLaughlin purchased 1,000 shares of BHRB at $63.55; 3 of 4 prior buys at this ticker showed strong 90-day gains.

Director Shawn Patrick McLaughlin acquired 1,000 shares at $63.55, bringing his holdings to 69,000 shares. Notably, he executed a buy on 2026-04-28 (the day before this trade), suggesting sustained conviction over consecutive trading days. His prior four measurable trades at BHRB show a 3-of-4 success rate on 90-day outcomes: the 2025-10-28 buy returned +5.1%, the 2025-05-29 buy returned +13.5%, and the 2025-05-07 buy returned +1.3%, while only the 2025-02-24 buy resulted in a -11.2% decline. The cumulative evidence of well-timed entry points at this specific ticker—combined with his continued purchasing activity—stands out against his cross-ticker record, which shows only a 57.89% 90-day win rate and -1.0% average 30-day return. Given the company's attractive P/E of 5.08 and the insider's demonstrated track record of favorable entry timing at BHRB, the transaction warrants investor attention.

Buy
1,000 shares
$64,800
Significance 6/10

Director's open-market purchase of 1,000 shares signals confidence in BHRB's fundamentally sound profile.

An insider director purchased 1,000 shares at market price, representing a modest addition to holdings during a period when the stock is trading below its recent highs but showing near-term recovery momentum. The company is profitable with a low valuation multiple and strong quarterly earnings, indicating solid underlying business fundamentals. The timing of this buy—after the stock pulled back but hasn't collapsed—suggests the insider sees value in a fundamentally sound financial services company, rather than panic-buying into a crisis or catching a falling knife. This disciplined, modest accumulation by someone with fiduciary responsibility is a constructive signal, particularly given BHRB's reasonable valuation and consistent profitability. While the purchase size is not dramatic, it reinforces management confidence at a point where the market may be undervaluing the business.

October 2025
Buy
1,000 shares
$61,000
Significance 3/10

Director McLaughlin buys 1,000 shares of BHRB at $61.00; stock down 13.8% from 52-week high at $71.04

Director Shawn Patrick McLaughlin purchased 1,000 shares of Burke & Herbert Financial Services Corp. at $61.00 on 2025-10-28, increasing his holdings from 66,000 to 67,000 shares. The transaction occurs with the stock trading at $61.26 (current), down 13.8% from its 52-week high of $71.04 and down 2.2% over the past 30 days. Examining McLaughlin's prior trades at BHRB, his timing has been mixed: two of five prior buys showed positive 90-day returns (the May 2025 purchases gaining 6.1% and 1.6% respectively), while three earlier purchases in late January and February 2025 showed 90-day declines ranging from -0.6% to -11.4%. His cross-ticker track record of 20 prior buys shows an average 90-day return of +1.1% with a 50% win rate, suggesting modest overall success timing buys across holdings. The company trades at a P/E of 8.80 with $29.9M net income and a $920.3M market cap, characteristics of a stable small-cap financial services firm.

May 2025
Buy
1,000 shares
$56,250
Significance 4/10

Director McLaughlin purchased 1,000 shares of BHRB at $56.25; holdings now 66,000. Cluster buy signal amid -19.9% drawdown from 52-week high.

Director Shawn Patrick McLaughlin purchased 1,000 shares at $56.25, adding to a position that now totals 66,000 shares. The transaction occurs as the stock trades $56.92 versus a 52-week high of $71.04—a decline of 19.9% from that peak—and follows a 90-day decline of 8.7%. His prior BHRB purchases at this ticker show an unfavorable timing record: all 4 measurable prior trades resulted in negative 90-day returns (ranging from -11.2% to -16.9%), with zero of four well-timed. His cross-ticker track record across 19 prior buys shows a 44.44% win rate and +0.4% average 90-day return. Notably, 2 other insiders purchased within the past 14 days, forming a cluster-buy pattern. The company's P/E of 14.78 and $854.1M market cap provide fundamental context, though this transaction remains modest relative to his existing 66,000-share position.

Buy
1,000 shares
$56,500
Significance 4/10

Director Shawn Patrick McLaughlin bought 1,000 shares at $56.50; cluster of 4 other insiders also bought within 14 days

McLaughlin's purchase of 1,000 shares at $56.50 increases his holding to 64,000 shares—a modest 1.6% addition to his position. The transaction occurs during a downward momentum window: the stock is currently at $56.23, down 20.8% from its 52-week high of $71.04 and down 13.9% over the past 90 days, though up 13.2% over the past 30 days. Critically, his prior trading record at BHRB shows zero well-timed buys across 5 previous transactions—all resulted in negative 90-day returns (ranging from -11.4% to -16.9%)—suggesting a pattern of purchasing before further declines. However, a cluster pattern is present: 4 other insiders also purchased within the past 14 days, which may indicate coordinated confidence in current valuations despite the unfavorable prior timing outcomes at this ticker.

February 2025
Buy
1,000 shares
$62,350
Significance 6/10

Director Shawn Patrick McLaughlin bought 1,000 shares of BHRB at $62.35; 3rd insider buy within 14 days as stock sits -12.6% from 52-week high.

McLaughlin purchased 1,000 shares at $62.35 on 2025-02-24, increasing his holding to 63,000 shares. The stock now trades at $62.09, down 12.6% from its 52-week high and down 10.3% over the past 90 days. The buy occurs within a cluster: two other insiders purchased within the past 14 days, suggesting coordinated or reinforcing signals about the equity's value. At his same-ticker BHRB trades, McLaughlin's prior measurable outcome was a +15.7% 90-day return on his August 2024 purchase, though his more recent December purchases showed negative 30-day returns of -12.5% and -16.9%. The company carries a P/E of 44.35 against $27.6M net income and a $929.3M market cap. The clustering of insider purchases in a period of stock weakness warrants attention to whether the insiders see value in the current price or whether emerging developments may explain the recent decline.

January 2025
Buy
1,000 shares
$63,000
Significance 6/10

Director Shawn Patrick McLaughlin purchases 1,000 shares at blended average $63.00, adding to 62,000-share holding; stock up +3.2% in 30 days.

McLaughlin executed two separate purchases on 2025-01-29 totaling 1,000 shares for $63,000.00 at a blended average price of $63.00, increasing his position from 61,000 to 62,000 shares. The stock is currently trading at $64.36, up +3.2% over the prior 30 days and up +2.3% over 90 days, modestly above his transaction prices. His prior trades at BHRB show a 3-of-3 win rate at the 90-day mark, though his two most recent December purchases (2024-12-09 and 2024-12-05) are down 16.9% and 12.5% respectively on the 30-day measure. The company reports net income of $27.6M and carries a P/E of 45.97, reflecting a premium valuation. This purchase represents a small 1.6% addition to his existing holdings and follows a pattern of continued accumulation at this ticker despite recent near-term losses on similar sized buys.

December 2024
Buy
555 shares
$38,489
Significance 6/10

Director Shawn Patrick McLaughlin buys 555 shares of BHRB at $69.35; 4 of 4 prior buys at this ticker achieved 90d gains of +5.7% to +29.2%.

Director McLaughlin purchased 555 shares at $69.35 on 2024-12-09, adding to a 61.0K-share position after the transaction. His prior trades at Burke & Herbert Financial Services Corp. show a consistent pattern: all 4 measurable buys since May 2024 achieved positive 90-day returns, ranging from +5.7% to +29.2%, indicating well-timed entry points at this specific ticker. The current price of $69.95 is only 1.5% below the 52-week high, and the stock has gained 8.4% over 90 days, contextualizing this purchase in a period of upward momentum. However, the stock trades at a P/E of 49.96 against net income of $27.6M and a market cap of $1.0B, suggesting a premium valuation relative to reported earnings.

Buy
195 shares
$13,552
Significance 5/10

Director Shawn Patrick McLaughlin buys 195 BHRB shares at $69.50; holdings rise to 60,445 shares; 4 of 5 prior buys at ticker yielded 90d gains.

McLaughlin purchased 195 shares at $69.50 on 2024-12-05, a small increment adding 0.3% to his 60.2K share position. The current price of $70.10 stands 1.3% above the transaction price, placing the stock near its 52-week high of $71.04. His prior transaction history at BHRB shows strong 90-day outcomes: 4 of 5 prior buys resulted in positive 90-day returns (ranging from +5.7% to +29.2%), establishing a 80% well-timed pattern at this ticker. The modest transaction size and the stock's current valuation near 52-week highs limit the signal strength, but the consistency of his prior buy timing at this company warrants attention to whether this incremental purchase precedes further gains.

August 2024
Buy
500 shares
$29,500
Significance 4/10

Director Shawn Patrick McLaughlin buys 500 BHRB shares at $59.00, holdings now 59,250 shares; stock up 25.6% in 30 days.

McLaughlin purchased 500 shares at $59.00 on 2024-08-09, increasing his stake to 59,250 shares, a modest 0.9% increase from his prior 58,750 shares. The stock has appreciated 25.6% over the prior 30 days and 23.6% over 90 days, trading at $60.36 current price and 12.2% below its 52-week high of $68.72. However, McLaughlin's prior buying history at BHRB shows mixed execution: of 5 prior trades at this ticker, only 1 of 3 measurable 90-day outcomes was well-timed (the May 1, 2024 buy returned +29.2% by 90 days), while his February 2024 and March 2024 purchases each fell 9-10% by the 90-day mark. His cross-ticker track record of 12 prior buys shows a 50% 90-day win rate with average 90-day returns of +1.9%, a modest baseline. The company's P/E of 44.06 against net income of $5,212,000 and market cap of $896,220,873.72 suggests a relatively expensive valuation context. This transaction reflects continued accumulation following a purchase just 4 days prior (2024-08-05) at the same price point, but recent stock momentum and prior buy-timing inconsistency at this ticker warrant observation.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access